ACRS Q2 2021 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$407M

Q2 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$2M-10.9% YoY

Gross Profit

$561,00030.8% margin

Operating Income

-$18M-987.2% margin

Net Income

-$18M-995.7% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

+2.6%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$288M

Total Liabilities

$54M

Stockholders' Equity

$234M

Cash & Equivalents

$113M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	-10.9%
Gross Profit	$561,000	$657,000	-14.6%
Operating Income	-$18M	-$11M	-58.2%
Net Income	-$18M	-$12M	-56.6%

Revenue Segments

Laboratory Research Revenue

$2M88%

Other Revenue

$218,00012%